Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States
Open Access
- 19 August 2004
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 351 (8) , 751-759
- https://doi.org/10.1056/nejmoa032510
Abstract
Tissue-banking organizations in the United States have introduced various review and testing procedures to reduce the risk of the transmission of viral infections from tissue grafts. We estimated the current probability of undetected viremia with hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and human T-lymphotropic virus (HTLV) among tissue donors.Keywords
This publication has 16 references indexed in Scilit:
- Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor populationTransfusion, 2002
- Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996Published by American Medical Association (AMA) ,2000
- Current viral risks of blood and blood productsAnnals of Medicine, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994.American Journal of Public Health, 1999
- New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention PurposesJAMA, 1998
- The Risk of Transfusion-Transmitted Viral InfectionsNew England Journal of Medicine, 1996
- Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United StatesNew England Journal of Medicine, 1995
- Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donorsTransfusion, 1995
- Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibodyTransfusion, 1994